Formulary decision guides

If you want to update your knowledge on specific drugs, or need to collate information to support your formulary decisions, read our Guidelines in Practice formulary decision guides

Formulary decision guides

trajenta fdg

Formulary decision guide: Trajenta® (linagliptin) 5 mg film-coated tablets

2018-06-08T15:08:00+01:00Promotional material from Boehringer Ingelheim Limited and Lilly Diabetes Alliance

Promotional material from Boehringer Ingelheim Limited and Lilly Diabetes Alliance

airflusal mdi fdg v6

Formulary decision guide: AirFluSal® MDI (salmeterol xinafoate and fluticasone propionate)

2018-04-23T08:40:00+01:00Commissioned by Sandoz Limited

Commissioned by Sandoz Limited

20180213 ikervis fdg v3

Formulary decision guide: Ikervis® (ciclosporin 1 mg/mL) eye drops

2018-03-20T11:56:00+00:00Commissioned by Santen UK Limited

Commissioned by Santen UK Limited

20180319 saflutan fdg v3 approved

Formulary decision guide: Saflutan® (tafluprost 15 micrograms/ml eye drops, solution, in single-dose container)

2018-03-19T17:08:00+00:00Commissioned by Santen UK Limited

Commissioned by Santen UK Limited

20180319 taptiqom fdg v2 approved

Formulary decision guide: Taptiqom® (tafluprost 15 micrograms/ml + timolol 5 mg/ml preservative-free eye drops)

2018-03-19T17:07:00+00:00Commissioned by Santen UK Limited

Commissioned by Santen UK Limited

Validate Accessibility